PTGS2 and cancer: Human endothelial cells stimulated with microparticles obtained from cancer patients post-VEGFi treatment induced a significant increase in gene expression of pro-inflammatory markers including TNF-α, IL-6, MCP-1, iNOS, COX-2, and VCAM-1 (Figures 6A–F).